Hello and Welcome to Patientsville.com, Your Source for all KENZEN information. We are dedicated to provide You with KENZEN safety information. Learn about KENZEN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
KENZEN Safety Reports
Total KENZEN reports: 16.KENZEN FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 13.
Take KENZEN Side Effects Survey or Share Your KENZEN Story. Read More Here.
Health Professional from FRANCE reported KENZEN problem on Dec 27, 2006. Male patient, 76 years of age, was diagnosed with hypertensive heart disease, transient ischaemic attack, prostate cancer, hypokalaemia, hyperuricaemia, prophylaxis and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, haemoglobin decreased, hyperkalaemia, hypokalaemia, hypotension, renal failure acute. KENZEN dosage: unknown. During the same period patient was treated with ASPIRIN, LASIX, HYPERIUM, DOXAZOSIN MESYLATE, ALDACTONE, DIFFU K, ALLOPURINOL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Health Professional from FRANCE on Jan 09, 2007. Male patient, 78 years of age, was diagnosed with hypertension, prophylaxis, hyperuricaemia, left ventricular failure, dermatomyositis and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: dehydration, dermatomyositis, diarrhoea, eosinophilia, international normalised ratio abnormal, left ventricular failure, lymphopenia, prothrombin time abnormal, prothrombin time shortened. KENZEN dosage: unknown. During the same period patient was treated with COUMADIN, ALLOPURINOL, PERINDOPRIL ERBUMINE, SIMVASTATIN, CORDARONE, CORTANCYL, LASIX. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported KENZEN problem on Jan 17, 2007. Male patient, 44 years of age, weighting 134.5 lb, was diagnosed with hypertension, epilepsy, asthma, rhinitis and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, bradycardia, cholinergic syndrome, gamma-glutamyltransferase increased, hypothermia, miosis. KENZEN dosage: unknown. During the same period patient was treated with DEPAKENE, TEGRETOL, URBANYL, SINGULAIR, DESLORATADINE. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Health Professional from FRANCE on Feb 13, 2007. Male patient, 76 years of age, was diagnosed with hypertensive heart disease, transient ischaemic attack, prostate cancer, hypokalaemia, hyperuricaemia, prophylaxis and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, hypotension, renal failure acute. KENZEN dosage: unknown. During the same period patient was treated with KARDEGIC, LASIX, HYPERIUM, DOXAZOSIN MESYLATE, ALDACTONE, DIFFU K, ALLOPURINOL, MOPRAL. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported KENZEN problem on Apr 05, 2007. Male patient, 74 years of age, was diagnosed with cardiomyopathy, diabetes mellitus, hypercholesterolaemia and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: atrioventricular block first degree, bundle branch block left, condition aggravated, heart rate decreased, hyperkalaemia, renal failure. KENZEN dosage: unknown. During the same period patient was treated with ALDACTONE, CARDENSIEL, LANTUS, PIROXICAM, LASIX, LIPUR, METFORMIN. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Health Professional from FRANCE on Apr 16, 2007. Male patient, 74 years of age, was diagnosed with cardiomyopathy, diabetes mellitus, hypercholesterolaemia and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: atrioventricular block first degree, bundle branch block, hyperkalaemia, renal failure. KENZEN dosage: unknown. During the same period patient was treated with ALDACTONE, CARDENSIEL, PIROXICAM, LANTUS, LASIX, LIPUR, METFORMIN. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported KENZEN problem on June 20, 2007. Female patient, 63 years of age, was diagnosed with hypertension and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, hypotension, hypovolaemia. KENZEN dosage: unknown. During the same period patient was treated with MEDIATENSYL, MORPHINE, ACUPAN. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Health Professional from FRANCE on Aug 18, 2006. Male patient, 79 years of age, was diagnosed with hypertension, diabetes mellitus non-insulin-dependent, atrial fibrillation, insomnia, cardiac failure and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: bladder cancer, bradycardia, dehydration, dialysis, haemoglobin decreased, hyperkalaemia, hypoglycaemia, metabolic acidosis, rectal cancer. KENZEN dosage: unknown. During the same period patient was treated with DIAMICRON, LASILIX, PREVISCAN, IMOVANE, CARDENSIEL. Patient died on 03/18/2006.
Health Professional from FRANCE reported KENZEN problem on Nov 27, 2006. Male patient, 85 years of age, weighting 172.0 lb, was diagnosed with hypertension, prophylaxis and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: dysphonia, laryngeal oedema. KENZEN dosage: unknown. During the same period patient was treated with EUPHON, TRIMETAZIDINE, FLUINDIONE, BISOPROLOL FUMARATE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Health Professional from FRANCE on Dec 04, 2006. Male patient, 80 years of age, was diagnosed with hypertensive cardiomyopathy, arthropathy, myocardial ischaemia, hypercholesterolaemia, benign neoplasm of prostate and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. KENZEN dosage: unknown. During the same period patient was treated with NUREFLEX, ASPEGIC, KREDEX, NITRODERM, PRAVASTATIN, XATRAL, ARANESP. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported KENZEN problem on Nov 27, 2006. Male patient, 85 years of age, weighting 172.0 lb, was diagnosed with hypertension, cough, angina pectoris, atrial fibrillation and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, dysphonia, laryngeal oedema. KENZEN dosage: unknown. During the same period patient was treated with EUPHON, TRIMETAZIDINE, PREVISCAN, BISOPROLOL FUMARATE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Health Professional from FRANCE on Dec 12, 2006. Male patient, 82 years of age, was diagnosed with acute pulmonary oedema and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: anaemia, fall, hyperkalaemia, iatrogenic injury, loss of consciousness, malaise, orthostatic hypotension, renal failure, stent placement. KENZEN dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, ISOPTIN, PLAVIX, CORDARONE, FONZYLANE, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported KENZEN problem on Dec 20, 2006. Male patient, 76 years of age, was diagnosed with hypertensive heart disease, transient ischaemic attack, prostate cancer, hypokalaemia, hyperuricaemia, prophylaxis and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: dehydration, haemoglobin decreased, hypotension, renal failure acute. KENZEN dosage: unknown. During the same period patient was treated with ASPIRIN, LASIX, HYPERIUM, DOXAZOSIN MESYLATE, ALDACTONE, DIFFU K, ALLOPURINOL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Physician from FRANCE on July 05, 2007. Female patient, 85 years of age, was diagnosed with hypertension and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: acquired epidermolysis bullosa. KENZEN dosage: unknown. During the same period patient was treated with ZANIDIP, ATARAX, KARDEGIC, FORLAX. Patient recovered.
Physician from FRANCE reported KENZEN problem on July 23, 2007. Female patient, 74 years of age, was diagnosed with myocardial infarction and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis. KENZEN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, KARDEGIC, KALEORID, PLAVIX, CARDENSIEL, LASIX, INEGY. Patient was hospitalized. Patient recovered.
KENZEN problem was reported by a Physician from FRANCE on Aug 07, 2007. Female patient, weighting 123.5 lb, was diagnosed with hypertension and was treated with KENZEN. After drug was administered, patient experienced the following problems/side effects: eosinophilia, pemphigoid. KENZEN dosage: unknown. During the same period patient was treated with ZANIDIP, ATARAX, KARDEGIC, FORLAX. Patient recovered.